NAD+ provider reviews

Publishes all four rungs — and advertises the one that costs a year.

Three NAD+ routes at one price, billed per four weeks not per month.

A fixed $99 for either route — advertised from inside a sale.

A real price matrix — that its own pages disagree about.

One kit, one honest price — on a route the company's own trials don't cover.

Publishes both NAD+ ladders in full, and sells no month.

The lowest standing NAD+ price here — and it says "starting at".

Three NAD+ routes, three prices, all on the public homepage.

One flat number on the product's own page — $199, no ladder, no code.

Publishes both numbers and names the lever between them.

Two routes, two published floors, and a page that stops there.

Publishes an NAD+ floor — on the homepage, but not on the NAD+ page.

An open FDA letter, and no advertised figure the seller calls final.

Package price for an 8-10 week supply, not a flat monthly rate.

A $89 first-month rate printed on the page — with the second-month price never stated.

The "$137" is a twelve-month prepay — month to month it is $199.

A $79 headline that turns out to be a prepaid quarter.

One variant, one price, and the store's own data proves it.

Four numbers for one product, and no policy pages to read them against.

Prints the standing rate honestly, then advertises only the first month.

A real published price, on a billing cycle that is not a month.

The advertised price is the medication only, and it says so.

The only price a reader can see here is a picture.

The only sublingual NAD+ here, and its only public price is a floor.

Two prices on the product page, and a third fee in section 28.

A nurse at your door, priced per session — and a site we cannot re-read.

The only thing here with randomized human trials behind it.

Practitioner-grade NR with a sport certification — at the highest per-capsule price here.

A patch named for a molecule it does not contain, by a route that does not work.

An open FDA warning letter sits on this company's record.

Unusually straight on price and states — and under an FDA letter.

The only provider here that prices NAD+ per fill instead of per month.

A clean "from $145/mo" floor for NAD+ — bundled with sermorelin, with no names behind it.

Men's-only, with a named advisor and a 503A claim — but no standalone NAD+ price exists.

A real NAD+ listing with no price attached to it anywhere on the site.

One company, two pricing cultures — and NAD+ got the honest one.

The ladder is inverted — month to month is the cheapest rung.

Sermorelin as a lozenge, NAD+ from $149 — and an open FDA letter.

A real NAD+ page its own markup tells Google to ignore.

A deep longevity menu with a price on none of it.

The strongest clinical bench in this module, and a $49 that needs two conditions.

A marketplace, not a clinic — and it sells no longevity medicine at all.

Publishes a full price ladder for its GLP-1 line and none for its NAD+ line.

The homepage's "$93 billed monthly" is the three-month prepay wearing a monthly label.

Prices NAD+ twice on the same day, $50 apart, on two of its own visible pages.

The cheapest published NAD+ injection rate here, printed with no "from" attached.

One plan at one price — served from pages another brand also serves.

A $199 NAD+ plan served from the same pages as Believe Health's.

The same three NAD+ products sold at two different price sets, on two of its own pages.

Every $135 it advertises is a three-month prepay divided by three.

"$199 /month" in the hero, "Billed every 28 days" on the plan card of the same page.

Qualifies its price "starting at" and then charges exactly that, with no tier behind it.

Every NAD+ headline equals no figure the same page computes.

A page titled "Transparent pricing" that blurs its own grid behind a members-only overlay.

Three different price sets for the same NAD+ products, all live at once.

Answers "all 50 states" and "seven states" at the same time, on the same site.

Sells NAD+ as a one-time cart item, so there is no monthly rate to quote.